Skip to content

Application of adductor canal block combined with infiltration between the popliteal artery and capsule of the posterior knee or oxycodone without background dose for patients undergoing total knee arthroplasty

Application of adductor canal block combined with infiltration between the popliteal artery and capsule of the posterior knee or oxycodone without background dose for patients undergoing total knee arthroplasty

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057722
Enrollment
Unknown
Registered
2022-03-15
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Experimental group 1:adductor canal block combined with infiltration between the popliteal artery and capsule of the posterior knee
Experimental group 2:adductor canal block combined with oxycodone for intravenous analgesia
Control group:adductor canal block

Sponsors

Xishan People's Hospital of Wuxi
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing unilateral total knee replacement for the first time; 2. In line with the indications of spinal anesthesia; 3. ASA I-?; 4. Aged 18-75 years, gender unlimited; 5. Get informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating patients; 2. Morbid obesity (BMI>=40kg/m^2); 3. Patients with severe heart, brain, liver and kidney diseases; 4. Patients with lower limb paralysis or limb sensory and movement disorders; 5. Patients with mental illness, inability to communicate properly, or inability to correctly score VAS; 6. Patients allergic to amides local anesthetics, opioids and other drugs; 7. Patients with a history of opioid or drug abuse; 8. Patients who failed spinal block and switched to other anesthesia methods; 9. Severe complications such as massive bleeding occurred during the operation.

Design outcomes

Primary

MeasureTime frame
Resting visual analog score;Visual analog score after exercise;

Secondary

MeasureTime frame
Effective pressure times of analgesia pump;Times and total amount of rescue opioids used;Muscle strength of quadriceps femoris;Block of common peroneal nerve;Maximum angle of active flexion of knee joint;Maximum distance of single walking;Serum IL-6;Serum IL-10;Serum C-reactive protein;Adverse events and adverse drug reactions;Patient satisfaction and comfort;

Countries

China

Contacts

Public ContactTang Li

Xishan People's Hospital of Wuxi

471354625@qq.com+86 510 82402084

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026